Researchers at Rice University and MD Anderson Cancer Center have developed a new AI-powered handheld microscope designed to improve early cancer detection. The device, called “PrecisionView,” combines advanced optics with artificial intelligence to provide high-resolution, real-time imaging of tissue directly at the point of care. Scientists say the technology could help doctors identify cancerous and precancerous tissue earlier without relying as heavily on invasive biopsies.
About the size of a pen, PrecisionView functions as a handheld endomicroscope capable of visualizing both cellular structures and underlying blood vessels across larger tissue areas than conventional systems. Researchers explained that the device uses a specially designed optical phase mask alongside AI reconstruction algorithms to overcome traditional trade-offs between image detail and depth of field. According to the study, the system achieves a field of view roughly five times larger and a depth of field about eight times greater than existing handheld imaging technologies while still maintaining cellular-level resolution.
The device has already shown promising results in early testing. Researchers used PrecisionView to image oral tissue in healthy volunteers and to detect precancerous cervical lesions in tissue samples. The AI-enhanced imaging system was able to clearly distinguish abnormal tissue from surrounding healthy areas in real time. Scientists believe this capability could help clinicians scan larger tissue regions instantly, reducing missed diagnoses and unnecessary biopsies while speeding up treatment decisions.
One of the most significant aspects of the project is its focus on affordability and accessibility. The system reportedly costs around $3,000 to build using relatively simple components, making it far less expensive than many traditional pathology imaging systems. Researchers say this could make advanced cancer diagnostics more accessible in low-resource clinics and underserved regions where pathology infrastructure is limited. While larger clinical trials are still needed before widespread use, experts believe the technology demonstrates how AI and medical imaging can work together to improve cancer screening and early detection worldwide.
